415 related articles for article (PubMed ID: 9705256)
1. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
2. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
3. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
4. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein.
Ishihara C; Miyazawa M; Nishio J; Chesebro B
J Immunol; 1991 Jun; 146(11):3958-63. PubMed ID: 2033265
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
[TBL] [Abstract][Full Text] [Related]
7. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
8. The envelopes of two ecotropic murine leukemia viruses display distinct efficiencies in retroviral vaccination by interference.
Corbin A; Richardson J; Denesvre C; Pozo F; Ellerbrok H; Sitbon M
Virology; 1994 Jul; 202(1):70-5. PubMed ID: 8009868
[TBL] [Abstract][Full Text] [Related]
9. Restriction of Friend virus-induced erythroid cell proliferation by CD4+ T-lymphocytes that recognize a single gp70 epitope.
Miyazawa M; Fujisawa R
Leukemia; 1997 Apr; 11 Suppl 3():227-9. PubMed ID: 9209349
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte responses to the envelope proteins of endogenous ecotropic and mink cytopathic focus-forming murine leukemia viruses in H-2b mice.
Coppola MA; Green WR
Virology; 1994 Jul; 202(1):500-5. PubMed ID: 7516600
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
[TBL] [Abstract][Full Text] [Related]
14. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
[TBL] [Abstract][Full Text] [Related]
15. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
16. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
17. Different H-2 subregions influence immunization against retrovirus and immunosuppression.
Morrison RP; Earl PL; Nishio J; Lodmell DL; Moss B; Chesebro B
Nature; 1987 Oct 22-28; 329(6141):729-32. PubMed ID: 2823142
[TBL] [Abstract][Full Text] [Related]
18. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
19. Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses.
Corbin A; Sitbon M
J Virol; 1993 Sep; 67(9):5146-52. PubMed ID: 8394442
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
